Recurrent Pseudomonas aeruginosa Infection in Chronic Lung Diseases: Relapse or Reinfection?

Ho-Kee Yum1, I-Nae Park1, Bo-Mun Shin2

  • 1Department of Internal Medicine, Inje University Seoul Paik Hospital, Seoul, Korea.

Abstract

Insights

Recurrent Pseudomonas aeruginosa pneumonia in chronic lung disease is often caused by the same bacterial strain relapsing. This suggests a need to understand persistent colonization to improve treatment strategies for chronic lung infections.

Area of Science:

  • Medical Microbiology
  • Pulmonary Medicine
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa infections cause progressive, chronic, and recurrent respiratory issues in conditions like COPD, bronchiectasis, and cystic fibrosis.
  • Treatment challenges arise due to P. aeruginosa's drug resistance and tendency for recurrence.

Purpose of the Study:

  • To investigate the strain relatedness of recurrent Pseudomonas aeruginosa pneumonia in patients with chronic lung disease.
  • To determine if recurrent infections are caused by distinct or persistent strains.

Main Methods:

  • Analyzed 48 sputum cultures from 18 patients with recurrent P. aeruginosa pneumonia.
  • Compared P. aeruginosa strains using antibiotic resistance patterns and pulsed-field gel electrophoresis (PFGE) for chromosomal fingerprinting.

Main Results:

  • Antibiotic resistance patterns did not correlate with previous antibiotic exposure.
  • Fifteen out of 18 patients (83.3%) experienced recurrent pneumonia caused by P. aeruginosa strains with identical PFGE patterns.

Conclusions:

  • The majority of recurrent P. aeruginosa infections in chronic lung disease stem from relapses of prior infections.
  • Further research is needed to elucidate molecular mechanisms of persistent colonization and develop strategies to eradicate clonal persistence.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
17
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
23
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
73
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
19
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K